Contamac announces FDA Premarket approval (PMA) of Optimum Infinite® (tisilfocon A) material for use in orthokeratology overnight wear.

Spanish German French Italian Portuguese Saffron Walden, Essex, UK – February 16, 2026 – Contamac, a global leader in specialty contact lens and intraocular lens materials today announced U.S. Food and Drug Administration (FDA) Premarket approval for the Optimum Infinite®  (tisilfocon A) Orthokeratology Lenses II. Outside the USA, this approval in one of...